Showing 281 - 300 results of 1,303 for search 'Eligible (novel)', query time: 0.11s Refine Results
  1. 281

    WIC staff and healthcare professional perceptions of an EHR intervention to facilitate referrals to and improve communication and coordination with WIC: A qualitative study by Abigail McCall, Ashley E. Strahley, Katy W. Martin-Fernandez, Kristina H. Lewis, Angelina Pack, Beatriz Ospino-Sanchez, Ivy Greene, Gabriela de la Vega, Alysha J. Taxter, Sally G. Eagleton, Kimberly G. Montez

    Published 2024-01-01
    “… Abstract Objectives: Participation in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) has numerous benefits, yet many eligible children remain unenrolled. This qualitative study sought to explore perceptions of a novel electronic health record (EHR) intervention to facilitate referrals to WIC and improve communication/coordination between WIC staff and healthcare professionals. …”
    Get full text
    Article
  2. 282

    Identification of biomarkers associated with Parkinson’s disease by gene expression profiling studies and bioinformatics analysis by Marios G. Krokidis

    Published 2019-12-01
    “…The identification and validation of novel biomarkers for the diagnosis of PD is a great challenge using contemporary approaches and optimizing sampling handling as well as interpretation using bioinformatics analysis. …”
    Get full text
    Article
  3. 283

    The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review by Robert Puckrin, Mona Shafey, Jan Storek

    Published 2023-01-01
    “…Although the use of allogeneic hematopoietic cell transplantation (HCT) for chronic lymphocytic leukemia (CLL) has declined with the development of novel targeted agents, it continues to play an important role for eligible patients with high-risk or heavily pretreated CLL who lack other treatment options. …”
    Get full text
    Article
  4. 284

    The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma by Omar Albanyan, Julio Chavez, Javier Munoz

    Published 2022-12-01
    “…Since the approval of anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy and novel agents, the treatment paradigm for DLBCL has changed remarkably. …”
    Get full text
    Article
  5. 285

    Addressing missed opportunities for cervical cancer screening in Nigeria: a nursing workforce approach by Okolie, EA, Aluga, D, Anjorin, S, Ike, FN, Ani, EM, Nwadike, BI

    Published 2022
    “…Consequently, existing screening services are opportunistic, sparsely distributed and have reached less than 9% of eligible Nigerian women. This article highlights the current status of cervical cancer screening in Nigeria, contextualises the role of female nurses and proffers novel approaches to address missed opportunities for screening by leveraging the nursing workforce.…”
    Journal article
  6. 286

    Innovative Development of Programmable Phase Change Materials and Their Exemplary Application by Kristin Lengsfeld, Moritz Walter, Martin Krus, Sandra Pappert, Christian Teicht

    Published 2021-06-01
    “…This article describes the development and use of a novel programmable phase change material (PCM) for latent heat storage applications. …”
    Get full text
    Article
  7. 287
  8. 288

    Role of Stem Cell Transplantation in Multiple Myeloma by Srinivas Devarakonda, Yvonne Efebera, Nidhi Sharma

    Published 2021-02-01
    “…Autologous stem cell transplantation (auto-SCT) has been the standard of care in eligible newly diagnosed multiple myeloma (MM) patients. …”
    Get full text
    Article
  9. 289

    A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review by Vijay Kumar Chattu, Prakash Narayanan, Anjali Pushkaran

    Published 2023-10-01
    “…Introduction The COVAX alliance is a novel approach to international partnership in global health intended to achieve the worthy goal of ‘COVID-19 vaccine equity’. …”
    Get full text
    Article
  10. 290

    Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) by Jan Philipp Bewersdorf, Amer M. Zeidan

    Published 2021-03-01
    “…Herein, we review the current management of MDS and CMML and conclude with a critical appraisal of novel therapies and general trends in this field.…”
    Get full text
    Article
  11. 291

    Osteoarthritis biomarkers: year in review by Watt, F

    Published 2017
    “…Control reference intervals, work on predictive validity and other longitudinal studies examining prognostic value of biomarkers in large cohorts are reviewed. 2) Novel studies relating to biomarkers of inflammation are discussed, including complement, the performance of markers of so-called 'cold inflammation' and results from clinical trials including biomarkers. 3) Discovery studies, including whole blood RNA, proteomics and metabolomics are reviewed, with an emphasis on new technologies.Discovery, characterisation and qualification of various biomarkers is ongoing; several novel protein and non-protein candidate biomarkers have been reported this year. …”
    Journal article
  12. 292

    Patient engagement during the transition from nondialysis‐dependent chronic kidney disease to dialysis: A meta‐ethnography by Jinjie Liu, Yujun Zhou, Yanyao Tang, Jieling Chen, Jianying Li

    Published 2023-12-01
    “…Meta‐ethnography was utilized to translate and synthesize the findings and develop a novel theoretical interpretation of ‘patient engagement’ during the transition to dialysis. …”
    Get full text
    Article
  13. 293

    Modeling the Impact of Nonpharmaceutical Interventions on COVID-19 Transmission in K-12 Schools by Yiwei Zhang, Maria E Mayorga, Julie Ivy, Kristen Hassmiller Lich, Julie L. Swann

    Published 2022-12-01
    “…Background. The novel coronavirus SARS-CoV-2 spread across the world causing many waves of COVID-19. …”
    Get full text
    Article
  14. 294

    Perioperative and palliative systemic treatments for biliary tract cancer by Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, Gerald W. Prager

    Published 2024-03-01
    “…Due to the fact biliary tract cancer (BTC) is often diagnosed at an advanced stage, thus, not eligible for resection, and due to the aggressive tumor biology, it is considered as one of the cancer types with the worst prognosis. …”
    Get full text
    Article
  15. 295

    Advances in Cryptographic Voting Systems by Adida, Ben

    Published 2015
    “…Voters should receive assurance that their intent was correctly captured and that all eligible votes were correctly tallied. The election system as a whole should ensure that voter coercion is unlikely, even when voters are willing to be influenced. …”
    Get full text
    Working Paper
  16. 296

    Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol by Kanika Chaudhri, Sonali R Gnanenthiran, Samantha Louise Saunders, Nathan Scott McOrist, Grant Shalaby

    Published 2022-10-01
    “…Introduction Whether bisphosphonates and RANKL inhibitors play a novel role in delaying cardiovascular calcification is unknown. …”
    Get full text
    Article
  17. 297

    Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma by William Jiang, Jelske M. de Jong, Richard van Hillegersberg, Matthew Read

    Published 2022-02-01
    “…All peer-reviewed full-text articles and conference abstracts were included. (3) Results: The search yielded 548 results of which 71 full-texts, conference abstracts and clinical trials were eligible for review. A total of 242 duplicates were removed, 191 articles were screened out, and 44 articles were excluded. (4) Discussion: Biomarkers were discussed in seven categories including imaging, epigenetic, genetic, protein, immunologic, blood and serum-based with remaining studies grouped in a miscellaneous category. (5) Conclusion: Although promising markers and novel methods have emerged, current biomarkers lack sufficient evidence to support clinical application. …”
    Get full text
    Article
  18. 298

    CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults by Veenith, T, Fisher, BA, Slade, D, Rowe, A, Sharpe, R, Thickett, DR, Whitehouse, T, Rowland, M, Scriven, J, Parekh, D, Bowden, SJ, Savage, JS, Richards, D, Bion, J, Kearns, P, Gates, S

    Published 2021
    “…Immunomodulation is, therefore, an attractive therapeutic strategy and we sought to test licensed and novel candidate drugs. <br><strong> Methods and analysis <br></strong>The CATALYST trial is a multiarm, open-label, multicentre, phase II platform trial designed to identify candidate novel treatments to improve outcomes of patients hospitalised with COVID-19 compared with usual care. …”
    Journal article
  19. 299

    Seeking to improve access to COVID-19 therapeutics in the remote Torres and Cape communities of Far North Queensland during the first COVID-19 omicron outbreak by Sarah Galloway, Caroline Taunton, Rittia Matysek, Allison Hempenstall

    Published 2022-10-01
    “…Conclusion: The COVID-19 Care at Home program demonstrated a novel, public health led approach to delivering time-critical medications to individuals across a large, remote and logistically complex region. …”
    Get full text
    Article
  20. 300

    Knowledge of legal rights as a factor of refugee and asylum seekers’ health status: a qualitative study by Tara C Pilato, Faten Taki, Kaitlyn Sbrollini, Amanda Purington Drake, Brian Maley, Stephen Yale-Loehr, Jane L Powers, Natalya N Bazarova, Aparajita Bhandari, Gunisha Kaur

    Published 2023-02-01
    “…However, there is an opportunity to utilise novel approaches, such as digital technologies, to communicate relevant information regarding legal rights and public benefits to advance the health of vulnerable individuals such as refugees and asylum seekers.…”
    Get full text
    Article